22:27:55 EST Tue 24 Feb 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Ocumetics Technology Corp
Symbol OTC
Shares Issued 129,187,106
Close 2026-02-24 C$ 0.43
Market Cap C$ 55,550,456
Recent Sedar+ Documents

Ocumetics appoints Marks as director

2026-02-24 18:09 ET - News Release

Mr. Dean Burns reports

OCUMETICS ANNOUNCES APPOINTMENT OF RAYMOND MARKS TO BOARD OF DIRECTORS

Raymond Marks has been appointed to Ocumetics Technology Corp.'s board of directors.

Mr. Marks was instrumental in the early fundraising efforts of the company and participated in meetings that resulted in Ocumetics securing financing for its initial public listing by reverse takeover.

He has over 50 years of experience as an entrepreneur, owner, operator and manager across a variety of industries, including the resource and industrial sectors. Throughout his career, Mr. Marks has worked with many such companies and has worked with growing companies to secure millions in financing for their strategic initiatives.

Mr. Marks previously co-founded Tudor Gold Corp. and served as executive vice-president and a director of Tudor from February, 2016, until October, 2018. Mr. Marks later assisted in the formation of Hanstone Capital Corp., which later became Hanstone Gold Corp., where he served as president and chief executive officer from October, 2018, until October, 2025. Mr. Marks helped secure over $16-million in financing for the two companies.

"We welcome Mr. Marks to the board of Ocumetics and look forward to benefiting from his capital markets experience and assistance with our next stage of fundraising," said Dean Burns, president and chief executive officer of Ocumetics.

About Ocumetics Technology Corp.

Ocumetics is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.

Ocumetics is in the first-in-human early feasibility study phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed an intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.